90Y-MOv18-Bz-DOTA conjugate
may be useful in radioimmunotherapy of ovarian carcinoma
Also Known As:
yttrium-90-MOv18-p-isothiocyanatobenzyl-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results